RT info:eu-repo/semantics/article T1 Social pharmacology: expanding horizons A1 Maiti, Rituparna A1 Alloza y Gascón-Molins, José Luis K1 Clinical pharmacology K1 drug abuse K1 Phase IV K1 post marketing period K1 sociopharmacology K1 Ciencia K1 Farmacología K1 Science K1 Pharmacology AB In the current modern and global society, social changes are in constant evolution due to scientific progress (technology, culture, customs, and hygiene) and produce the freedom in individuals to take decisions by themselves or with their doctors toward drug consumption. In the arena of marketed drug products which includes society, individual, administration, and pharmaceutical industry, the young discipline emerged is social pharmacology or sociopharmacology. This science arises from clinical pharmacology, and deals with different parameters, which are important in creating knowledge on marketed drugs. However, the scope of “social pharmacology” is not covered by the so‑called “Phase IV” alone, but it is the science that handles the postmarketing knowledge of drugs. The social pharmacology studies the “life cycle” of any marketed pharmaceutical product in the social terrain, and evaluates the effects of the real environment under circumstances totally different in the drug development process. Therefore, there are far‑reaching horizons, plural, and shared predictions among health professionals and other, for beneficial use of a drug, toward maximizing the benefits of therapy, while minimizing negative social consequences. PB Wolters Kluwer SN 0253-7613 YR 2014 FD 2014-05-09 LK http://hdl.handle.net/10017/20272 UL http://hdl.handle.net/10017/20272 LA eng DS MINDS@UW RD 28-mar-2024